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Abstract
Intracerebral hemorrhage (ICH), defined as bleeding within the brain parenchyma, 
remains a challenging and controversial neurosurgical entity to treat. ICH has a broad 
range of etiology—stemming from complications associated with traumatic head injury 
to complications of hemorrhagic stroke. The role of medical management lies in optimiz-
ing blood pressure and intracerebral pressure, preventing secondary injury from compli-
cations of the hematoma such as seizures, and correcting coagulopathy. Given the mass 
effect of a hematoma and the possibility of expansion, surgical interventions attempt to 
evacuate the clot to restore normal intracerebral pressure and prevent worsening neuro-
logic injury. This chapter reviews the recent controversy associated with surgical evacu-
ation of intracerebral hemorrhage placing particular emphasis on the size and location 
of the hemorrhage and the methods used to evacuate the expanding ICH. Moreover, this 
chapter reviews considerations and therapeutic goals of the preoperative and postopera-
tive window to minimize complications and optimize patient care.
Keywords: intracerebral hemorrhage, hemorrhagic stroke, surgical intracerebral hemorrhage, 
neurosurgical interventions
1. Introduction
Intracerebral hemorrhage (ICH) is defined as bleeding that takes place within the brain paren-
chyma and impacts 63,000 people annually within the United States [1, 2]. ICH is a major 
complication of traumatic brain injury and contributes to 15% of strokes [3]. Many etiolo-
gies are implicated in ICH, including hypertension, vascular anomalies, amyloid angiopathy, 
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 coagulopathy, brain malignancies, pregnancies, and substance abuse. Depending on the extent 
of hemorrhage and additional risk factors, ICH prognosis can be highly variable. Extensive 
hemorrhage has been associated with greater than 30% mortality rate within one month of 
injury with only 30% of patients returning to independent functioning by 6 months [4].
Medical management aims to optimize blood pressure, intracerebral pressure (ICP), coagu-
lopathy, seizure control, fever control, and deep vein thrombosis prophylaxis. Additionally, 
surgical management aims to prevent neurologic decline through surgical decompression of 
the skull and evacuation of expanding hematoma [5]. However, the role of surgery in man-
agement for ICH remains controversial, and numerous trials have been conducted examining 
the indications and efficacy of prompt surgical intervention. This chapter will explore the cur-
rent scientific literature regarding the indications and efficacy of neurosurgical intervention 
in the management of patients with ICH.
2. Preoperative diagnostics and workup
ICH presents with acute-onset focal neurologic deficits, headache (approximately 40% of 
patients), elevated systolic blood pressure (50%), nausea, and vomiting (50%) [5–7]. Common 
deficits include, in order of decreasing incidence, paresis, sensory deficits, speech deficits, vision 
changes, and gait disturbances [6]. Symptoms are often progressive due to hematoma expansion, 
which tends to occur within the first several hours following ICH. However, patients without 
hemorrhage growth may still experience substantial neurological deterioration within the first 
24 hours [8]. Electrographic seizures may occur in up to a third of patients with ICH, although 
only half of these are clinically significant [9]. Seizures are more likely to occur with cortical 
involvement of ICH and may be associated with neurological deterioration and increased mid-
line shift [10, 11]. Patients commonly have altered mental status, and those with large or grow-
ing hematomas may experience rapid worsening in Glasgow Coma Scale (GCS) [12].
Non-contrast computed tomography (CT) scan is considered to be the “gold standard” for 
diagnosis of new ICH and detection of other forms of intracranial bleeding that may present 
concomitantly [13]. Magnetic resonance imaging (MRI) may also be beneficial in identifying 
microhemorrhages, and CT angiogram is sensitive in identifying secondary causes of intrapa-
renchymal bleeding such as aneurysm rupture, vasculitis, intracranial malignancy, or arterio-
venous malformations [14, 15].
In an emergency setting, ensuring adequate airway, breathing, and cerebral perfusion is 
essential. For patients with a GCS < 8, transtentorial herniation, intraventricular hemorrhage, 
or hydrocephalus, an ICP monitor should be placed to dynamically monitor cerebral perfu-
sion pressure [16]. Management of elevated ICPs in the acute setting includes elevating the 
head of bed to 30°, sedation, intubation, and hyperventilation of the patient to a PaCO₂ of 
25–30 and rapidly infusing hypertonic saline or mannitol while preparing the operating room 
for surgical decompression or clot evacuation [9, 17]. Management of hemorrhagic mass effect 
and acute hydrocephalus via external ventricular drain is beneficial for ICP measurement 
and cerebrospinal fluid (CSF) diversion in these patients and has been shown to significantly 
reduce mortality in the setting of intraventricular  hemorrhage [18, 19].
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3. Surgical management
The role of surgery in the treatment of intracerebral hemorrhage remains a matter of debate. 
Though many clinical trials have attempted to better characterize the role of surgical evacu-
ation in ICH, variability in factors such as location and volume of the bleed and method of 
surgical intervention have long limited extrapolation to guidelines. Much less controversy 
surrounds the surgical management of infratentorial ICH due to proximity to the brain stem 
and the possibility of catastrophic injury and complications [20, 21]. For this reason, posterior 
fossa hematomas greater than 3 cm are evacuated due to the significant risk of brain stem 
compression and hydrocephalus [22].
Regardless of the cause of ICH, close monitoring of complications such as hypertension, 
hematoma expansion, perihematomal edema, seizures, intraventricular hemorrhage leading 
to hydrocephalus, and venous thromboembolism is vital to patient survival and prevention 
of functional deficits [23]. In addition to reducing intracranial pressure, surgical evacuation 
reduces clot volume, which contributes to both mechanical compression of the brain and 
neurotoxic edema [24]. Despite these perceived benefits, clinical trials prior to 2004 failed to 
demonstrate a clear survival difference in patients offered surgical intervention and medi-
cal treatment compared to conservative medical management. For example, a multicenter 
randomized controlled trial utilizing minimally invasive, stereotactic approaches with low-
dose tissue plasminogen activator (tPA) for liquefaction and aspiration of clot (SICHPA trial) 
demonstrated effective reduction of clot size compared to conservative treatment, but no dif-
ferences were found in 180-day mortality rates [25].
Five trials from 1989 to 2003 demonstrated equivocal outcomes following surgical interven-
tion. Encouraging functional outcomes were demonstrated in a small study of stereotac-
tic evacuation of putaminal hemorrhages in 2004 [26]. The International Surgical Trial in 
Intracerebral Hemorrhage (STICH) randomized over 1000 patients with spontaneous basal 
ganglia and/or lobar hemorrhages to surgery within 24 hours of presentation versus early 
conservative management with possible surgical evacuation after 24 hours in the setting of 
neurological deterioration to examine the efficacy of early surgical clot evacuation. Though 
the trial found only 26% of surgical patients had favorable outcomes at 6 months compared to 
24% in the medical management group, subgroup analysis demonstrated that patients with 
supratentorial ICH with hematomas 1 cm or less from the cortical surface had improved out-
comes with surgical evacuation compared with patients with deep hematomas and conserva-
tive management [27].
To follow up on this finding, over 600 patients with 10–100 mL superficial lobar hemorrhages 
and no intraventricular hemorrhage (IVH) were randomized to evacuation within 12 hours 
plus medical treatment compared to medical management alone with the option for subse-
quent surgical intervention for neurological deterioration in the STICH II trial in 2013 [28]. 
This trial demonstrated similarly statistically insignificant findings. Mortality at 6 months 
was 18% in the early surgery group compared to 24% in the medical management group, with 
an absolute difference of 5.6%. Though the surgery group demonstrated no vegetative sur-
vivors through 6 months and the distribution of Extended Glasgow Outcome Scale (GOS-E) 
scores was more favorable in the surgery group, neither of these findings was statistically 
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significant. However, subgroup analysis of patients with poor prognosis before treatment 
defined as GCS 9–12 demonstrated more favorable outcome with surgery (odds ratio of poor 
outcome: 0.49, 95% confidence interval 0.26–0.92, p = 0.02). Based upon the results of the 
STICH II trial, the investigators concluded that patients with higher GCS of 13–15 do not 
demonstrate survival advantage with early surgery if given the option of delayed surgery if 
deterioration occurs.
The CLEAR IVH trial and MISTIE trial are ongoing investigations that use minimally inva-
sive technique with assistance of low-dose tPA [29]. Preliminary results from the MISTIE II 
trial demonstrated minimally invasive aspiration with low-dose tPA reduced clots to 50% 
of the stabilized volume within the first week, compared to a 6% reduction with medical 
management alone. Though statistically significant increases in symptomatic bleeding were 
not seen with the use of tPA (2.4% in the minimally invasive plus tPA group versus 9.3% in 
the medical management group), the authors did caution that the use of minimally invasive 
techniques with tPA did increase asymptomatic hemorrhages (22.2% versus 7.1%, p = 0.051). 
These results demonstrate the safety and efficacy of these interventions compared with con-
servative management alone [30]. Furthermore, hematoma evacuation has been shown to sig-
nificantly reduce perihematomal edema, even when combined with tPA delivered to the clot 
[31]. The MISTIE Intraoperative Stereotactic Computed Tomography-Guided Endoscopic 
Surgery (MISTIE ICES) trial [32] was recently completed and demonstrated 42.9% of surgi-
cal patients had functional neurological outcomes defined as a modified Rankin scale score 
(mRS) of 0–3, compared to 23.7% in the medical management group at 180 and 365 days (p 
= 0.19). These results demonstrate the safety and efficacy of CT-guided endoscopic surgery 
to remove acute ICH. Examples of endoscopic hemorrhage evacuation can be found below 
(Figures 1–3).
Figure 1. (A and B): Axial and coronal MRI demonstrating right-sided preoperative intracerebral hemorrhage involving 
the right ventricle.
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Figure 3. Follow-up axial CT scan after endoscopic hemorrhagic evacuation demonstrating resolution of clot.
Figure 2. (A and B): Intraoperative endoscopic clot evacuation using minimally invasive technique.
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4. Endoscopic hemorrhage evacuation example
Taken together, the results of these trials demonstrate the difficulties in producing guidelines 
for the surgical management of ICH (Figures 1–3). Though surgical intervention demonstrates 
better outcomes in early trials, these findings do not reach statistical significance. Like many 
neurosurgical studies, many of these trials suffer from significant patient crossover and highly 
variable patient characteristics. It has been argued that the subjectively better outcomes in early 
trials are of clinical relevance, especially when patients are projected to have poor outcomes as 
a result of the location or volume of their bleed. More recent trials have demonstrated the safety 
and efficacy of endoscopic measures combined with low-dose tPA in dissolving clots, reducing 
edema, and improving outcomes to a statistically significant degree. Endoscopic approaches to 
ICH will likely become more widely utilized as more data from clinical trials becomes available.
5. Postoperative management
Postoperative management of ICH includes ensuring appropriate blood pressure control, fre-
quent neurologic examinations, deep vein thrombosis prophylaxis, and gastric ulcer prophy-
laxis. Subsequent physical therapy and rehabilitation especially in the first month after ICH 
has been shown to be more effective in increasing independence with activities of daily life 
and motor function when compared to controls [33].
Despite limited evidence of long-term postoperative management of ICH, studies suggest 
that ICH patients would benefit from a systolic blood pressure of <130 mmHg. Patients, nota-
bly, with established small vessel disease see a 60% risk reduction in recurrent ICH with these 
blood pressure guidelines [9]. Furthermore, studies have shown that in patients with poor 
clinical grade or coexisting cardiopulmonary complications, early hemodynamic stabilization 
is associated with lower rates of delayed cerebral ischemia, lower 90-day mRS, and lower 
length of intensive care unit stay [34].
Deep vein thrombosis (DVT) prophylaxis after ICH is a current area of uncertainty. Various stud-
ies, including the CLOTS3 trial, show reduction in asymptomatic DVT with the use of intermit-
tent pneumatic compression devices in ICH patients. Similarly, low molecular weight heparin or 
unfractionated heparin can be used for DVT prophylaxis in patients with stable hematomas or 24 
hours after craniotomy [35]. There is little current evidence to suggest positive or negative out-
comes of mortality with gastric ulcer prophylaxis for ICH patients. A randomized controlled trial 
comparing ranitidine, sucralfate, and placebo for gastric hemorrhage prophylaxis in ICH patients 
showed no significant difference in mortality or pneumonia. However, given the increased preva-
lence of gastric ulcers in these patients, prophylaxis should be initiated based on current data [36].
6. Conclusion
Intracerebral hemorrhage remains a serious complication associated with head trauma and a 
consequence of hemorrhagic stroke. Appropriate diagnosis and management of  intracerebral 
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pressures and ventilation preoperatively remains an important opportunity to improve patient 
outcomes. While surgical intervention for large infratentorial ICH is clearly beneficial, the role 
of supratentorial ICH remains controversial given the diversity of ICH locations, depth of 
bleed, and technique used to evacuate the hemorrhagic clot. Superficial cortical ICH can have 
improved outcomes with surgical evacuation compared to medical management alone, and 
image-guided endoscopic evacuation of clot also shows promise. ICH patients can have a host 
of complications in the postoperative window and require close follow-up to prevent subse-
quent surgical and medical complications. Further prospective trials elucidating whether sur-
gical intervention compared to medical management alone is optimal given an ICH location, 
presentation, or volume of hemorrhage will continue to guide the management of this diverse 
population.
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